Menu
Recruiting NCT02831335

Technical Development of Multi-Parametric Renocerebral MRI

— Observational Aging

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: MRI, MRI, MRI, Group 4.
Who it may be relevant to
Registry conditions: Aging. Basic parameters: 21 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and functional MRI methods along with a battery of cognitive tests.

Interventions

  • Other MRI
    Perform MRI studies
  • Other MRI
    Perform MRI studies
  • Other MRI
    Perform MRI studies
  • Other Group 4
    Perform MRI studies

Primary outcome measures

  • MRI measured perfusion for each group [Time frame: Baseline]
  • MRI measured vascular reactivity for each group [Time frame: Baseline]
  • Cognitive performance for each group [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • English-speaking as primary language
  • No hearing loss or uncorrected vision

Exclusion criteria

  • Lacking capacity to consent
  • Having known history of cardiovascular diseases (e.g., clinical stroke)
  • Having acute and chronic obstructive pulmonary disease
  • Having known history of renal diseases (e.g., acute kidney injury)
  • Having known history of cognitive disorder or psychiatric illness
  • Having known history of chemical dependence (e.g., alcohol and narcotics)
  • Being treated with stimulant medications, anticonvulsants, antihypertensives or ß-adrenergic blockers

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Center for Magnetic Resonance Research — Minneapolis

Identifiers

NCT: NCT02831335 · 1603M85492

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗